A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer
Clinical trial NCT00091442 · COMPLETED
Trial details
- NCT number
- NCT00091442
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2008-12-01
- Enrollment
- 751
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.